Economic evaluation of ASCOT -BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen

P Lindgren, M Buxton, T Kahan, N. R Poulter, Björn Dahlöf, P. S Sever, H Wedel, B Jönsson, Markku S Nieminen, ASCOT trial investigators

    Research output: Contribution to journalArticleScientific

    Original languageEnglish
    JournalHeart
    Volume94
    Pages (from-to)e4
    Number of pages1
    ISSN1355-6037
    Publication statusPublished - 2008
    MoE publication typeB1 Journal article

    Cite this

    Lindgren, P., Buxton, M., Kahan, T., Poulter, N. R., Dahlöf, B., Sever, P. S., Wedel, H., Jönsson, B., Nieminen, M. S., & ASCOT trial investigators (2008). Economic evaluation of ASCOT -BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen. Heart, 94, e4.